Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related CPHD
Stocks Hitting 52-Week Lows
Mid-Morning Market Update: Markets Mostly Flat; General Motors Earnings Top Expectations
Related ABT
Time To Buy Mylan's Clear Path To EPS Upside, JP Morgan Says
Goldman Is Downgrading Abbott Laboratories

Analysts at Piper Jaffray downgraded Cepheid (NASDAQ: CPHD) from “overweight” to “neutral.” Cepheid's shares closed at $34.09 yesterday. Cepheid's trailing-twelve-month ROE is -12.52%.

Analysts at Deutsche Bank downgraded Abbott Laboratories (NYSE: ABT) from “buy” to “hold.” Abbott's shares closed at $33.27 yesterday. Abbott's PEG ratio is 0.51.

Analysts at Goldman Sachs downgraded Wells Fargo & Company (NYSE: WFC) from “buy” to “neutral.” Wells Fargo's shares closed at $34.76 yesterday. Wells Fargo's trailing-twelve-month profit margin is 23.18%.

Raymond James downgraded First Solar (NASDAQ: FSLR) from “market perform” to “underperform.” First Solar's shares closed at $34.41 yesterday. First Solar's trailing-twelve-month ROA is 2.17%.

Latest Ratings for CPHD

Nov 2015Stifel NicolausInitiates Coverage onBuy
Oct 2015Canaccord GenuityDowngradesSpeculative BuyHold
Oct 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for CPHD
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (CPHD + ABT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters